Elebsiran, an antiviral agent against hepatitis B and D virus infections, is a small interfering RNA (siRNA) therapeutic designed to target and silence specific mRNA sequences responsible for the production of pathogenic proteins. Its mechanism of action involves the degradation of targeted mRNA, thereby preventing the synthesis of proteins that contribute to disease progression.
Chemical Structure:
BOC Sciences is a leading provider of DNA and RNA products and services that meet the needs of researchers and pharmaceutical companies worldwide. Its broad product portfolio includes various types of oligonucleotides, DNA/RNA synthesis feedstocks, RNA interference tools, and advanced drug delivery systems, among others. Designed to promote cutting-edge research and innovative therapeutic solutions, at BOC Sciences you are sure to find the right product for you.